Health System Tracker
- Industry
KFF Analysis Finds Medical Prices Outpaced Overall Inflation Since 2000
In a Peterson-KFF Health System Tracker brief, KFF reports that medical care prices grew 133% between January 2000 and October 2026, compared with 100% growth in prices for all consumer goods and services. Hospital prices more than quadrupled (314% growth) over that period, outpacing every other major CPI-U expenditure category, while nursing home (179%) and dental (163%) prices also grew faster than medical care overall. Prescription drug prices rose 94% since 2000, roughly in line with overall consumer inflation. The brief notes that in the short term, from September 2025 to September 2026, overall consumer inflation (3.7%) exceeded medical inflation (1.5%), and that data reflect a gap from the October 2025 government shutdown.
- Federal Policy
Hospital Price Transparency Data Still Hampers Rate Comparisons
In a Peterson-KFF Health System Tracker analysis, researchers examine how CMS's revised hospital price transparency rule, effective January 2026 with enforcement beginning April 2026, affects the usability of hospital pricing data. The revisions require hospitals to encode negotiated rates as dollar values whenever determinable in advance, and to report new "allowed amounts" (median, percentile, and payment counts) when rates are expressed as percentages or algorithms instead. Reviewing sample admission codes using Turquoise Health's aggregated data, the authors find clearer CMS guidance has improved reporting precision, but several issues still complicate comparability: dollar-amount fields are used inconsistently for both base and final rates, some arrangements generate duplicate-looking rate entries, and hospitals inconsistently use algorithm versus free-text note fields, affecting whether additional payment detail is captured.
- Industry
Healthcare Jobs Drive Nearly All US Employment Growth
In a Peterson-KFF Health System Tracker analysis, researchers report that healthcare has added 372,000 jobs (up 2.0%) since September 2025, while the rest of the economy added just 124,000 jobs (up 0.1%), based on BLS data. The piece notes healthcare now represents an all-time-high 11.7% share of total US employment, driven by an aging population, chronic disease prevalence, and jobs that resist automation. It also flags downside risk: CBO projects over 10 million more uninsured people by 2036 due to ACA and Medicaid policy changes, which could strain hospital revenues and slow healthcare job growth, particularly given hospitals' obligation to treat emergency patients regardless of ability to pay.
- Federal Policy
KFF Analysis Finds TrumpRx Prices Below OECD Average for 17 of 32 Brand-Name Drugs
A Peterson-KFF Health System Tracker analysis compared prices for 32 brand-name drugs on TrumpRx.gov—a federal portal launched in February 2026 offering medications from manufacturers that signed voluntary pricing agreements with the White House—to publicly listed prices in 11 wealthy OECD countries. TrumpRx prices were lower than the OECD peer average for 17 drugs and higher for 15; TrumpRx had the lowest price for 5 drugs and the highest for 13. The analysis does not assess whether these negotiated prices affect Medicaid or Medicare reimbursement, whether domestic prices outside TrumpRx have changed, or how the retail prices compare to net costs after rebates in Medicaid or other public programs.
- Industry
ACA Marketplace Premiums Rise in 2027 Rate Filings
Health insurers have submitted 2027 rate filings to state regulators for individual market plans sold through ACA Marketplaces, showing premium increases. The filings detail insurer expectations and the factors driving rate changes for the coming plan year. Rate filings occur annually each spring and summer as part of the regulatory approval process. This development affects individual market plans, which operate separately from Medicaid managed care but may inform broader health plan pricing trends and cost drivers affecting the commercial insurance market.